Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery.

Li BZ, Chen ZL, Shi SS, Feng XL, Tan XG, Zhou F, He J.

Chin J Cancer. 2013 Jul;32(7):403-9. doi: 10.5732/cjc.012.10233. Epub 2013 Mar 8.

2.

Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

Clin Transl Oncol. 2006 Jan;8(1):22-30.

PMID:
16632436
3.

Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.

Nakamura T, Hayashi K, Ota M, Ide H, Takasaki K, Mitsuhashi M.

Dis Esophagus. 2004;17(4):315-21.

PMID:
15569370
4.
5.

Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.

Samejima R, Kitajima Y, Yunotani S, Miyazaki K.

Anticancer Res. 1999 Nov-Dec;19(6C):5515-21.

PMID:
10697609
6.

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.

PMID:
12738305
7.

Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.

Kang SY, Han JH, Lee KJ, Choi JH, Park JI, Kim HI, Lee HW, Jang JH, Park JS, Kim HC, Kang S, Oh YT, Chun M, Kim JH, Sheen SS, Lim HY.

Clin Cancer Res. 2007 Jul 15;13(14):4146-53.

8.

Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.

Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):425-33.

PMID:
12957254
9.

REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.

Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, Watanabe H, Maruyama K, Okuyama M, Ogawa J.

Ann Surg Oncol. 2006 Dec;13(12):1724-31. Epub 2006 Sep 30.

PMID:
17009160
10.

CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.

Feng Z, Guo W, Zhang C, Xu Q, Zhang P, Sun J, Zhu H, Wang Z, Li J, Wang L, Wang B, Ren G, Ji T, Tu W, Yang X, Qiu W, Mao L, Zhang Z, Chen W.

PLoS One. 2011;6(10):e26399. doi: 10.1371/journal.pone.0026399. Epub 2011 Oct 31.

11.

[Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].

Zhang P, Xie CY, Wu SX.

Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):773-7. Chinese.

PMID:
18396692
12.

Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.

Zhai Y, Hui Z, Wang J, Zou S, Liang J, Wang X, Lv J, Chen B, Zhu H, Wang L.

Dis Esophagus. 2013 Jul;26(5):503-9. doi: 10.1111/j.1442-2050.2012.01380.x. Epub 2012 Aug 2.

PMID:
22862289
13.

Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.

Cao XF, He XT, Ji L, Xiao J, Lv J.

Dis Esophagus. 2009;22(6):477-81. doi: 10.1111/j.1442-2050.2008.00910.x.

PMID:
19703071
14.

Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.

Goan YG, Hsu HK, Chang HC, Chou YP, Chiang KH, Cheng JT.

Ann Thorac Surg. 2005 Sep;80(3):1007-16.

PMID:
16122475
15.

Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.

Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1049-59.

PMID:
9539559
16.

Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma.

Nagasawa S, Onda M, Sasajima K, Makino H, Yamashita K, Takubo K, Miyashita M.

J Surg Oncol. 2001 Nov;78(3):208-14.

PMID:
11745809
17.

High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy.

Zhu H, Wang Q, Hu C, Zhang W, Quan L, Liu M, Xu N, Xiao Z.

Tumour Biol. 2011 Dec;32(6):1147-53. doi: 10.1007/s13277-011-0217-y. Epub 2011 Aug 9.

PMID:
21826474
18.

Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.

Lu JC, Tao H, Chen ZZ, Qian PD.

Dis Esophagus. 2009;22(6):490-5. doi: 10.1111/j.1442-2050.2008.00936.x. Epub 2009 Jan 23.

PMID:
19191849
19.

Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.

Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R, Kyzas PA, Filipits M.

J Oral Pathol Med. 2012 Jan;41(1):40-6. doi: 10.1111/j.1600-0714.2011.01071.x. Epub 2011 Aug 29.

PMID:
21883486
20.

CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.

Miyata H, Doki Y, Shiozaki H, Inoue M, Yano M, Fujiwara Y, Yamamoto H, Nishioka K, Kishi K, Monden M.

Clin Cancer Res. 2000 Dec;6(12):4859-65.

Items per page

Supplemental Content

Write to the Help Desk